TWO SIGMA INVESTMENTS, LP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 36 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$398,590
-31.5%
273,007
+7.4%
0.00%0.0%
Q2 2023$582,242
+213.6%
254,254
+24.6%
0.00%0.0%
Q1 2023$185,683
-22.3%
204,047
-27.4%
0.00%0.0%
Q4 2022$239,009
-32.1%
281,187
-34.6%
0.00%0.0%
Q3 2022$352,000
-1.4%
429,708
+19.0%
0.00%0.0%
Q2 2022$357,000
-56.8%
361,034
-28.4%
0.00%
-50.0%
Q1 2022$827,000
-63.1%
504,155
-45.8%
0.00%
-60.0%
Q4 2021$2,242,000
+229.7%
930,447
+562.5%
0.01%
+150.0%
Q3 2021$680,000
-17.8%
140,455
-54.6%
0.00%0.0%
Q2 2021$827,000
-23.0%
309,653
-11.2%
0.00%
-33.3%
Q1 2021$1,074,000
+678.3%
348,756
+586.9%
0.00%
+200.0%
Q2 2020$138,000
-34.0%
50,776
-48.8%
0.00%
-50.0%
Q1 2020$209,000
-64.6%
99,258
-8.6%
0.00%0.0%
Q4 2019$591,000
+206.2%
108,599
+69.6%
0.00%
+100.0%
Q3 2019$193,000
+10.3%
64,048
+36.6%
0.00%0.0%
Q2 2019$175,000
-31.9%
46,904
-26.6%
0.00%0.0%
Q1 2019$257,000
+2.0%
63,861
-7.0%
0.00%0.0%
Q4 2018$252,00068,7000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$4,782,3991.67%
TOWERVIEW LLC 342,478$500,0180.33%
Orbimed Advisors 6,943,654$10,137,7350.22%
SAMLYN CAPITAL, LLC 2,405,764$3,512,4150.06%
BVF INC/IL 1,370,947$2,001,5830.05%
JACKSON SQUARE CAPITAL, LLC 63,773$93,1090.04%
MYDA Advisors LLC 68,814$100,4680.03%
Masso Torrence Wealth Management Inc. 10,000$14,6000.01%
Hikari Power Ltd 49,959$730.01%
XTX Topco Ltd 19,244$28,0960.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders